This series of free online events from The Michael J. Fox Foundation is designed for researchers and clinicians. Each session features presentations on a hot topic in Parkinson’s research and therapeutic development from leaders in the field as well as opportunity for discussion and questions.
Innovating from Drug Discovery through the Clinic: Novel Approaches to PD Therapeutic Development
This two-day event in November will showcase the latest advances in Parkinson’s drug development. Day one will highlight new tools and platforms for drug discovery while day two will feature innovative research programs from the Foundation’s funding portfolio. Please note you will have to register separately for each day.
-
Day 1: Diverse Approaches Accelerating PD Target and Drug Screening
Tuesday, November 9, 2021
11 a.m. to 12:30 p.m. ETLeaders from academia and industry will highlight platforms including DNA-encoded libraries, predictive AI-powered programs, and optogenetics. We’ll cover how these technologies are fueling advances in drug discovery for neuroscience and Parkinson’s.
-
Day 2: Progress in the PD Pipeline: A Snapshot of MJFF’s Funded Programs
Wednesday, November 10, 2021
11 a.m. to 12:30 p.m. ETThis webinar will showcase novel translational and clinical research from MJFF's research portfolio including presentations from both academic and industry labs. Field leaders will share new and unpublished results and highlight progress in the therapeutic pipeline for Parkinson's disease.
-
Stay Up to Date
Join our email list for researchers and clinicians for the latest on upcoming webinars, funding opportunities, new resources (tools, datasets, biospecimens) and relevant news to accelerate research and patient care.
And download our free booklet which provides an overview of the 2020 webinars series and includes additional resources for researchers.
Past Webinars Available on Demand
-
Patient-Focused Drug Development: Novel Instruments to Capture Patient Outcomes in Parkinson’s
June 2020
Assessments that meaningfully measure the patient experience are critical tools for clinical trials. This session focuses on MJFF-funded research to identify the symptoms and aspects of disease burden that matter to people living with Parkinson’s. -
Molecular Signatures of Parkinson’s Disease
July 2020
MJFF’s landmark study, the Parkinson’s Progression Markers Initiative (PPMI) has generated a large set of biological, clinical and imaging data to inform translational biomarker research as well as novel therapeutic development. This session delves into the available data and shares some of the key insights to date from analysis of the PPMI dataset. -
The Many Faces of Parkinson's
September 2020
This virtual “patient day” brings together industry professionals, people with Parkinson’s and care partners to share experiences of Parkinson’s; its varying onset, progression, and symptoms; and unmet needs. -
Where We Are & Where We Are Heading: A Look Ahead at Therapeutic Development in Parkinson’s
October 2020
Leaders from academia and industry discuss the momentum in our field and look ahead to what’s next. The panel covers therapeutic development from identifying novel targets through advancing compounds to the clinic with an emphasis on emerging trends and opportunities to accelerate future development. -
The Promise of Precision Medicine for Parkinson’s Disease
February 2021
Panelists discuss clinical heterogeneity in Parkinson’s disease; using genetic, biologic and pathologic signatures for designing clinical trials; and precision medicine approaches for Parkinson’s. -
Using Patient Voices to Transform Your Parkinson's Research
June 2021
Panelists discuss why it’s critical to bring patients and care partners into the research & development process early and often. -
Centering Equity and Inclusion to Advance PD Therapeutic Development
September 2021
Panelists discuss approaches to make Parkinson’s research more inclusive, ensuring on-time recruitment and representative trial populations.
Event Sponsors
These events are brought to you by Biogen, MeiraGTx and Neuraly with additional support provided by AbbVie, Abcam, BBK, Bristol Myers Squibb, Charles River, IQVIA, Merck & Co., Inc., Kenilworth, NJ, USA and Sage Therapeutics.
Interested in Sponsorship Opportunities? Contact our Stakeholder Engagement team at researchpartnerships@michaeljfox.org for information about 2021 opportunities.
Partner with Us
If you are interested in learning more about sponsorship opportunities for the webinar series, please reach out to researchpartnerships@michaeljfox.org.